Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
268
-
Total 13F shares, excl. options
-
55.8M
-
Shares change
-
+2.49M
-
Total reported value, excl. options
-
$3.59B
-
Value change
-
+$179M
-
Put/Call ratio
-
1.02
-
Number of buys
-
122
-
Number of sells
-
-154
-
Price
-
$64.35
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2020
341 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q1 2020.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.8M shares
of 66.6M outstanding shares and own 83.83% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6.79M shares), FMR LLC (5.57M shares), VANGUARD GROUP INC (5.29M shares), BlackRock Inc. (4.4M shares), Invesco Ltd. (1.66M shares), FEDERATED HERMES, INC. (1.43M shares), STATE STREET CORP (1.31M shares), GILDER GAGNON HOWE & CO LLC (1.27M shares), BROWN CAPITAL MANAGEMENT LLC (1.11M shares), and EAGLE ASSET MANAGEMENT INC (956K shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.